US FDA's advisors bless quick licensing route for H1N1 vaccines
24 July 2009
Sue Sutter
The US
FDA's outside experts endorsed the agency's plans to license unadjuvanted vaccines against the novel influenza A/H1N1 virus without new clinical efficacy and safety data. However, the committee had trouble reaching a consensus on whether one or two doses of the vaccine should initially be recommended...
Please Login to read the full article.
24 July 2009
Sue Sutter
Please Login to read the full article.
RELATED CONTENT
NEWS
- US Capitol Capsule: With wish granted, Collins forges ahead with new translational science centre
- US FDA approves flu vaccine formulations for 2011-12 season; firms start shipping
- US Capitol Capsule: Obama jobs push may bode well for patent reform
- Pharma can sign up to help in the next flu pandemic, but may worry about IP rights
EVENTS
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
26 March 2012
Copenhagen, Denmark
JOB OF THE WEEK
Promote your vacancy here
